XCOPRI
LIVE

Serial Number

88485671

Owner

SK Biopharmaceuticals Co., Ltd.

Attorney

Hun Joon Kim

Filing Date

Jun 24, 2019

Add to watchlist:

No watchlists yet
View on USPTO

XCOPRI Trademark

Serial Number: 88485671 • Registration: 6110858

XCOPRI is a trademark filed by SK Biopharmaceuticals Co., Ltd. on June 24, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SK Biopharmaceuticals Co., Ltd. (18 trademarks)

221, Pangyoyeok-ro
Gyeonggi-do 13494 , KR

Entity Type: 03

Trademark Details

Filing Date

June 24, 2019

Registration Date

July 28, 2020

Published for Opposition

May 12, 2020

Goods & Services

Medicines for human purposes and veterinary preparations for treatment of central nervous system diseases, cancer and metabolic diseases; sanitary preparations for medical use; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; ferments for pharmaceutical purposes; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; bacteriological preparations for medical and veterinary use; blood solvent, namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 28, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 27, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 27, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 27, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 27, 2024 REAP
REGISTERED-PRINCIPAL REGISTER
Jul 28, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 7, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2020 CRFA
ASSIGNED TO LIE
Mar 23, 2020 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 16, 2020 ERSI
ASSIGNED TO EXAMINER
Oct 7, 2019 DOCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 16, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 16, 2019 GNSL
SUSPENSION LETTER WRITTEN
Sep 16, 2019 CNSL
ASSIGNED TO EXAMINER
Sep 12, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 3, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 2, 2019 NWOS
NEW APPLICATION ENTERED
Jun 27, 2019 NWAP